Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in specific keratin genes cause improper hair structure in mice due to faulty keratin protein assembly.

Reducing SOX2 in colorectal cancer cells decreases tumor growth and self-renewal.

The analysis of a large pilomatricoma revealed five distinct areas with different gene activity related to hair growth and tumor development.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Cellular senescence can both hinder and promote hair growth, suggesting new ways to treat hair loss.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

CIP/KIP proteins help stop cell division and support hair growth.

Deleting TNFα gene reduces skin cancer risk in certain mice.

High mTORC1 activity slows hair growth and causes it to lose color.

The conclusion is that a brown halo around hair follicles, seen in rapid hair loss, might be linked to inflammation or chemical exposure.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Hair stops producing melanin as it transitions from the growth phase to the resting phase.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

New mutations in hair keratin genes cause the rare hair disorder monilethrix.

CRH causes hair loss by reducing cell survival in hair follicles.

Hox proteins help maintain keratinocyte identity by regulating miRNA expression.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.

TPA is about 50 times more effective at promoting tumors than MZ.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

A woman had temporary hair loss after scalp surgery, which is a rare but self-healing condition that surgeons should recognize to avoid wrong treatment.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Cancer can hijack the body's cell repair system to promote tumor growth, and targeting this process may improve cancer treatments.